Whitney Ijem

Senior Vice President, Strategy & Business Development • Krystal Biotech

Whitney Ijem is SVP, Strategy and Business Development at Krystal. Before Krystal, she was a Managing Director and Senior Biotechnology Analyst covering genetic medicine and rare disease companies at Guggenheim Securities. Prior to Joining Guggenheim, Ms. Ijem was a therapeutics analyst at Tourbillon Capital where she focused on companies across the therapeutics space. Prior to Tourbillon, she was an analyst in the J.P. Morgan Equity Research Healthcare group focused on biotechnology. Before joining J.P. Morgan, Ms. Ijem was a biotech analyst at Canaccord Genuity. She holds a B.S. in Biomedical Engineering from Washington University in St. Louis and a M.S. in Biomaterials Science from New York University.

Also Speaking

Robert Newman

Chief Scientific Officer • Fujifilm Irvine Scientific

Metin Kurtoglu

Chief GMP Manufacturing Officer • Cartesian Therapeutics

Maria Croyle

Professor of Molecular Pharmaceutics and Drug Delivery/Glaxo Wellcome Professor • University of Texas at Austin

Event Info


Fun Run